Harmony Biosciences Holdings annual capital expenditures (capex)
2019
2020
2021
2022
2023
2024
2025
Harmony Biosciences Holdings Capital Expenditures (CapEx) Growth & History (HRMY)
Harmony Biosciences Holdings's capital expenditures (capex) was $310,000 for fiscal 2025.
View full Harmony Biosciences Holdings company overviewHarmony Biosciences Holdings annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $310,000 | −$843,000 | −73.11% |
| 2024 | 2024-12-31 | $1.2M | $841,000 | +269.55% |
| 2023 | 2023-12-31 | $312,000 | $140,000 | +81.40% |
| 2022 | 2022-12-31 | $172,000 | −$126,000 | −42.28% |
| 2021 | 2021-12-31 | $298,000 | $296,000 | +14800.00% |
| 2020 | 2020-12-31 | $2,000 | −$147,000 | −98.66% |
| 2019 | 2019-12-31 | $149,000 | — | — |
Harmony Biosciences Holdings quarterly capital expenditures (capex)
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $107,000 | −$406,000 | −79.14% |
| Q3 2025 | 2025-09-30 | $71,000 | $68,000 | +2266.67% |
| Q2 2025 | 2025-06-30 | $4,000 | −$628,000 | −99.37% |
| Q1 2025 | 2025-03-31 | $128,000 | $123,000 | +2460.00% |
| Q4 2024 | 2024-12-31 | $513,000 | — | — |
| Q3 2024 | 2024-09-30 | $3,000 | $3,000 | — |
| Q2 2024 | 2024-06-30 | $632,000 | — | — |
| Q1 2024 | 2024-03-31 | $5,000 | — | — |
| Q3 2023 | 2023-09-30 | $0 | −$86,000 | — |
| Q4 2022 | 2022-12-31 | $0 | $0 | — |
| Q3 2022 | 2022-09-30 | $86,000 | −$7,000 | −7.53% |
| Q2 2022 | 2022-06-30 | $41,000 | −$160,000 | −79.60% |
| Q1 2022 | 2022-03-31 | $45,000 | $41,000 | +1025.00% |
| Q4 2021 | 2021-12-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $93,000 | $93,000 | — |
| Q2 2021 | 2021-06-30 | $201,000 | — | — |
| Q1 2021 | 2021-03-31 | $4,000 | — | — |
| Q3 2020 | 2020-09-30 | $0 | — | — |
Harmony Biosciences Holdings capital expenditures (capex) trends
Over the last five fiscal years, Harmony Biosciences Holdings's capital expenditures (capex) increased from $2,000 to $310,000, a change of $308,000. The latest reported quarter, Q4 2025, shows $107,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Harmony Biosciences Holdings source filings ↗